Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial

• Katherine A. Sutherland,

  Affiliation University College London, London, United Kingdom

  ⨯
• Chris M. Parry,

  Affiliation Uganda Research Unit on AIDS, Medical Research Council (MRC), Uganda Virus Research Institute, Entebbe, Uganda

  ⨯
• Adele McCormick,

  Affiliation University College London, London, United Kingdom

  ⨯
• Anne Kapaata,

  Affiliation Uganda Research Unit on AIDS, Medical Research Council (MRC), Uganda Virus Research Institute, Entebbe, Uganda

  ⨯
• Fred Lyagoba,

  Affiliation Uganda Research Unit on AIDS, Medical Research Council (MRC), Uganda Virus Research Institute, Entebbe, Uganda

  ⨯
• Pontiano Kaleebu,

  Affiliation Uganda Research Unit on AIDS, Medical Research Council (MRC), Uganda Virus Research Institute, Entebbe, Uganda

  ⨯
• Charles F. Gilks,

  Affiliation School of Population Health, University of Queensland, Brisbane, Australia

  ⨯
• Ruth Goodall,

  Affiliation MRC Clinical Trials Unit at UCL, London, United Kingdom

  ⨯
• Moira Spyer,

  Affiliation MRC Clinical Trials Unit at UCL, London, United Kingdom

  ⨯
• Cissy Kityo,

  Affiliation Joint Clinical Research Centre, Kampala, Uganda

  ⨯
• Deenan Pillay ,

  * E-mail: dpillay@africacentre.ac.za (DP); ravindra.gupta@ucl.ac.uk (RKG)

  Affiliations University College London, London, United Kingdom, Wellcome Trust Africa Centre for Health and Population Sciences, University of KwaZulu Natal, Mtubatuba, South Africa

  ⨯
• Ravindra K. Gupta ,

  * E-mail: dpillay@africacentre.ac.za (DP); ravindra.gupta@ucl.ac.uk (RKG)

  Affiliation University College London, London, United Kingdom

  ⨯
• DART Virology Group

  ¶Membership of the DART Virology Group is listed in the Acknowledgments.

  ⨯